Gladstone NOW: The Campaign Join Us on the Journey ✕
46 - 60 of 429 Results Clear All
Magnus Hoffmann explains the science behind cancer vaccines and how they could change the game.
Gladstone Experts Cancer Infectious Disease
The San Francisco Standard—In this opinion piece, Melanie Ott, director of the Gladstone Institute of Virology, writes that halting mRNA research right now is like banning ChatGPT—it's not just scientific negligence, but strategic self-sabotage. She proposes ways for California to take the lead by funding crucial research at the state level.
Gladstone Experts Cancer COVID-19 HIV/AIDS Infectious Disease Ott Lab
ABC7 News—Scientific advances have brought us closer than ever to contemplating cures for many devastating diseases—Parkinson’s, type 1 diabetes, certain cancers, HIV/AIDS. Gladstone President Deepak Srivastava comments on how proposed cuts to the National Institutes of Health budget would slow this progress and the very research that could save millions of lives. He explains why this moment matters and why continued investment in science is critical.
Gladstone Experts Srivastava Lab
ABC7 News—Gladstone alumnus Arye Elfenbein and his business partner, Justin Kolbeck, founded Wildtype to create cell-cultured seafood. Their company uses the same technology—known as induced pluripotent stem cells—that Elfenbein learned while working in the lab of Deepak Srivastava at Gladstone.
Gladstone Experts Srivastava Lab
An in-depth explainer about different types of vaccines and what happens in the body after vaccination.
Gladstone Experts COVID-19 Deep Dive
Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.
Awards Gladstone Experts Doudna Lab
Gladstone unites more than 600 biologists, chemists, engineers, and data scientists, combining diverse expertise to uncover how the human body functions—and what drives disease.
Communications Gladstone Experts Institutional News
ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab
Discover Magazine—With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling this complex disease. In fact, Gladstone Investigator Yadong Huang and his colleagues at UCSF discovered that a combination of two cancer drugs could reduce brain degeneration and restore memory, pointing toward a potent treatment path never considered before.
Gladstone Experts Alzheimer’s Disease Huang Lab
NBC News—Gladstone Investigator Yadong Huang comments on a new study he helped lead, in which two cancer drugs showed signs of slowing or reversing symptoms of Alzheimer’s disease.
Gladstone Experts Alzheimer’s Disease Huang Lab
For World Brain Day, discover some of Gladstone’s latest breakthroughs in neurological research.
Gladstone Experts Research (Publication) Alzheimer’s Disease COVID-19 Parkinson’s Disease Neurological Disease Akassoglou Lab Corces Lab Huang Lab Mucke Lab
Cancer Research Institute—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, helps explain how AI will transform the future of cancer treatment and how scientists are shaping the next wave of progress in cancer immunotherapy.
Gladstone Experts Cancer Genomic Immunology Marson Lab
The San Francisco Standard—Gladstone President Deepak Srivastava discusses the promise of true, scientifically proven stem-cell treatments—but shares concerns about international clinics that market stem-cell therapies without any evidence.
Gladstone Experts Srivastava Lab Stem Cells/iPSCs
For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.
Gladstone Experts Cancer Genomic Immunology Data Science and Biotechnology Pelka Lab
San Francisco Chronicle—Gladstone Investigator Nadia Roan helps make sense of the conflicting guidance from federal health officials around who should get vaccinated against COVID-19. (Subscription may be required.)
Gladstone Experts COVID-19 Roan Lab
